Clinical Trial Update: Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents

View source ↗

Summary

The clinical trial evaluating the effects of antimuscarinic drugs on overactive bladder symptoms following ureteral stent insertion has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Antimuscarinic drugs (unspecified)

Snippet

Sponsor: Meir Medical Center | Conditions: Overactive Bladder | Status: WITHDRAWN